系统性红斑狼疮患者衰弱与衰弱前期的患病率:系统综述与荟萃分析
该系统综述与荟萃分析检索四个数据库至2024年11月,纳入15项研究共46,060例系统性红斑狼疮(SLE)患者,汇总分析显示SLE患者衰弱汇总患病率为27%(95%CI:19%-36%),衰弱前期汇总患病率为65%(95%CI:54%-76%)。作者结论认为衰弱与衰弱前期在SLE患者中高度流行,亟需更好地理解与处理该人群的衰弱问题以改善结局与生活质量。
要点
- SLE患者衰弱汇总患病率为27%(95%CI:19%-36%)
- SLE患者衰弱前期汇总患病率为65%(95%CI:54%-76%)
- SLICC-FI评估的衰弱患病率为26%(95%CI:14%-41%),Fried表型为22%(95%CI:18%-26%)
核心结论
- 衰弱与衰弱前期在SLE患者中均高度流行,作者认为亟需更好地理解与处理该人群的衰弱问题以改善患者结局与生活质量。
研究设计与样本
- 系统综述与荟萃分析,系统检索PubMed、Cochrane、EMBASE与Web of Science四个数据库自建库至2024年11月,纳入符合预设纳入标准且专门研究SLE患者衰弱与衰弱前期的研究。
- 共纳入15项研究,合计46,060例SLE患者,采用纽卡斯尔-渥太华量表(NOS)进行纳入研究的质量评价。
主要发现
- SLE患者衰弱汇总患病率为27%(95%CI:19%-36%)。
- SLE患者衰弱前期汇总患病率为65%(95%CI:54%-76%)。
- 亚组分析显示,采用系统性红斑狼疮国际合作组衰弱指数(SLICC-FI)评估时衰弱患病率为26%(95%CI:14%-41%),采用Fried表型(FP)评估时为22%(95%CI:18%-26%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Frailty is associated with mortality in systemic lupus erythematosus (SLE), but the prevalence is unclear. The aim of this systematic review and meta-analysis was to investigate the prevalence of frailty and prefrailty in SLE patients. METHODS: Four databases, namely PubMed, Cochrane, EMBASE, and Web of Science, were systematically searched from their inception to November 2024 to identify studies that fulfilled the predefined a priori inclusion criteria for systematic review and meta-analysis, and that specifically investigated frailty and prefrailty in patients with SLE. The quality assessment of the included studies was conducted according to the Newcastle-Ottawa scale (NOS). RESULTS: Fifteen studies were retrieved according to the inclusion criteria, and their data were combined in the eventual review. Data from studies including 46,060 patients with SLE were included. The analysis showed that the pooled prevalence of frailty in patients with SLE was 27 % (95 % CI: 19 % - 36 %), the pooled prevalence of prefrailty was 65 % (95 % CI: 54 % - 76 %). Analysis of subgroups revealed that the prevalence of frailty was 26 % (95 % CI: 14 % to 41 %) when measured by Systemic Lupus International Collaborating Clinics-Frailty Index (SLICC-FI) and 22 % (95 % CI: 18 % to 26 %) when assessed using Fried phenotype (FP). CONCLUSION: Both frailty and prefrailty are highly prevalent conditions among patients with SLE. There is an urgent need to better understand and address frailty in this population to enhance patient outcomes and quality of life.
引用
- Sang N, Zhang HH, Zhang MY, et al. Prevalence of frailty and prefrailty in systemic lupus erythematosus: A systematic review and meta-analysis. Semin Arthritis Rheum. 2025. PMID: 40086156. doi:10.1016/j.semarthrit.2025.152709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。